PYCR1 and nonpapillary renal cell carcinoma: The high expression of PYCR1 promoted the drug resistance of ccRCC cell lines to cyclopamine, IC-87114, MK-2206, and other drugs but enhanced the drug sensitivity of ccRCC cell lines to CGP-082996 (Figure 11(c)).